“To date, Adverse Events flowing from these products are at historically unprecedented levels globally and continue to rise. And again, to date, no other drugs in human history have reported more deaths, illnesses, injuries, and disabilities, which number as follows (to 28 June 2022):”
“Mr. Plothe’s data is shocking. He shares slides of his charts on a wide range of ‘vaccine’ affects, including drops in fertility around the world, accumulation of lipid nanoparticles and spike proteins in the various organs of the body, and the fact that the risk of miscarriage with the Covid ‘vaccines’ is over 1500 times higher than with the flu vaccine.”
From Geert: This is typical human behavior: blame it on the animals! Although the authors acknowledge that monkeypox virus (MPV) has persisted via human-to-human transmission, they don't seem to be bothering about the reason for such rapid human-to-human transmission. Instead they concentrate on rodents and foxes that ''have established interactions with potentially contaminated urban waste and sewage” to explain why spillback events may turn these animals into reservoirs of MPV. That may certainly be the case, but wouldn't it be wise to first investigate why humans in highly vaccinated countries seem to serve as reservoirs? Why does nobody investigate a potential link with large scale C-19 vaccination campaigns in those countries?
From Geert: Can you believe the report doesn't even state whether this person was C-19 vaccinated or not??? I tend to disagree with the following statement of the author:
"The lack of both sexual exposure and anogenital involvement indicates that mode of transmission may be associated with clinical symptoms".
Detection of virus in nasopharyngeal samples and saliva do not rule asymptomatic transmission upon close contact. This patient reported numerous close, nonsexual contacts with unknown persons, none of whom had skin lesions; in addition, he had such close contacts over 4 days during a series of outdoor events.
One can, therefore, not rule out that this patient got exposed to a high dose of MPV shed by an asymptomatic carrier; As already suggested, vaccinees in highly vaccinated countries (e.g., UK) are likely to serve as asymptomatic carriers for MPV(https://www.voiceforscienceandsolidarity.org/scientific-blog/monkeypox)
“There has been a significant rise in the number of A (H1N1) cases, or the swine flu, across Maharashtra with the highest number of patients in Pune, Mumbai, Thane, Nagpur, Kolhapur and Nashik. From January till mid-August at least 1,449 persons were detected with swine flu and 43 persons died of the infection.”
“This year, though, has been different: highly pathogenic avian influenza H5N1 (usually shortened to HPAI), has persisted into the hotter months and found its way into more wild birds than ever before, with the pathogen ripping through densely packed colonies of great skuas, gannets, Arctic terns, sandwich terns and herring gulls. It has also killed birds of prey.”
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.